Skip to main content
logo
Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
2.770
-0.240 (-7.97%)
At close: Oct 7, 2026, 4:00 PM EDT
2.890
+0.120 (4.33%)
Pre-market: Oct 8, 2026, 4:00 AM EDT

MTNB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.13.190.03
Revenue Growth
----65.62%9560.61%-79.16%
Cost of Revenue
-0.0911.4314.4916.6814.58
Gross Profit
--0.09-11.43-13.39-13.49-14.55
Selling, General & Admin
6.676.888.7310.3711.110.19
Operating Expenses
6.676.888.7310.3711.110.19
Operating Income
-6.67-6.96-20.16-23.77-24.59-24.74
Interest Expense
-0-0-0-0-0-0
Other Non Operating Income (Expenses)
-0.18-0.260.260.833.591.46
EBT Excluding Unusual Items
-6.85-7.22-19.9-22.94-21-23.28
Impairment of Goodwill
---2.09---
Gain (Loss) on Sale of Assets
-0.210.04----
Asset Writedown
---2.34---
Other Unusual Items
0.37-3.16----
Pretax Income
-6.69-10.35-24.33-22.94-21-23.28
Income Tax Expense
---0.08---
Net Income
-6.69-10.35-24.25-22.94-21-23.28
Preferred Dividends & Other Adjustments
0.620.62---0.4
Net Income to Common
-7.31-10.96-24.25-22.94-21-23.68
Net Income Growth
------
Shares Outstanding (Basic)
000000
Shares Outstanding (Diluted)
000000
Shares Change
20.84%12.50%11.98%0.21%3.16%6.75%
EPS (Basic)
-17.87-30.04-74.76-79.20-72.63-84.50
EPS (Diluted)
-17.87-30.04-74.76-79.20-72.63-84.50
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6.42-7.01-15.89-15.5-20.05-15.48
Free Cash Flow Per Share
-15.70-19.21-48.97-53.49-69.35-55.25
Operating Margin
----2168.43%-771.33%-74954.54%
Profit Margin
----2093.25%-658.63%-71754.54%
Free Cash Flow Margin
----1413.87%-628.86%-46918.18%
EBITDA
-6.66-6.92-19.79-23.37-24.23-24.46
D&A For EBITDA
0.010.040.370.390.360.28
EBIT
-6.67-6.96-20.16-23.77-24.59-24.74
SEC Filings: 10-K · 10-Q